Description
Specifications
| Presentation | 1mg single vial |
|---|---|
| Form | Oral tablet/capsule |

5-Alpha Reductase Inhibitor / 4-Azasteroid
Finasteride is a synthetic 4-azasteroid and selective inhibitor of type II 5-alpha reductase, with an extensive indexed research literature across endocrinology, dermatology, and urology.
$1.75
Research-grade Finasteride — 1mg tablet. For laboratory research use only.
PubMed Literature Index
3510
studies indexed in the public literature
Q2 2026 · view PubMed search ↗
In the literature, finasteride is described as a competitive inhibitor of type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). Studies characterize the resulting reduction in circulating and tissue DHT and the downstream effects investigated in androgen-dependent processes.
| CAS | 98319-26-7 |
| Formula | C23H36N2O2 |
| Mol. Weight | 372.5 g/mol |
| PubChem CID | 57363 |
In the published literature finasteride is studied primarily for 5-alpha reductase inhibition and reduction of dihydrotestosterone (DHT), and androgen-dependent processes.
Yes. Finasteride is an FDA-approved drug (marketed as Proscar and Propecia). It is sold here for laboratory research use only and not for human consumption.
Store in a cool, dry place, protected from light and moisture, per standard research handling.
Every lot is third-party tested before release.
Certificates of analysis are published per lot as testing completes.
PMID 35920739 · PMID 34291720 · PMID 34634163 · PMID 33814544 · PMID 29447628
Materials referenced on this page are intended for laboratory research purposes. No claims regarding therapeutic efficacy are made or implied. Not for human or veterinary use. Not evaluated by the FDA. Must be 21+.
| Presentation | 1mg single vial |
|---|---|
| Form | Oral tablet/capsule |
| Presentation | 1mg single vial |
|---|---|
| Form | Oral tablet/capsule |
Reviews
There are no reviews yet.